190 related articles for article (PubMed ID: 36092718)
1. The female syndecan-4
Støle TP; Lunde M; Shen X; Martinsen M; Lunde PK; Li J; Lockwood F; Sjaastad I; Louch WE; Aronsen JM; Christensen G; Carlson CR
Front Cell Dev Biol; 2022; 10():908126. PubMed ID: 36092718
[No Abstract] [Full Text] [Related]
2. Syndecan-4
Rønning SB; Carlson CR; Aronsen JM; Pisconti A; Høst V; Lunde M; Liland KH; Sjaastad I; Kolset SO; Christensen G; Pedersen ME
Front Cell Dev Biol; 2020; 8():730. PubMed ID: 32850844
[TBL] [Abstract][Full Text] [Related]
3. The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy.
Luckey SW; Walker LA; Smyth T; Mansoori J; Messmer-Kratzsch A; Rosenzweig A; Olson EN; Leinwand LA
J Mol Cell Cardiol; 2009 May; 46(5):739-47. PubMed ID: 19233194
[TBL] [Abstract][Full Text] [Related]
4. Exploring Syndecan-4 and MLP and Their Interaction in Primary Cardiomyocytes and H9c2 Cells.
Støle TP; Lunde M; Gehmlich K; Christensen G; Louch WE; Carlson CR
Cells; 2024 May; 13(11):. PubMed ID: 38891079
[TBL] [Abstract][Full Text] [Related]
5. Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3beta signaling pathway.
Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
Peptides; 2010 Jul; 31(7):1326-33. PubMed ID: 20416349
[TBL] [Abstract][Full Text] [Related]
6. Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation.
Zhu Y; Pereira RO; O'Neill BT; Riehle C; Ilkun O; Wende AR; Rawlings TA; Zhang YC; Zhang Q; Klip A; Shiojima I; Walsh K; Abel ED
Mol Endocrinol; 2013 Jan; 27(1):172-84. PubMed ID: 23204326
[TBL] [Abstract][Full Text] [Related]
7. RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways.
Shang L; Ananthakrishnan R; Li Q; Quadri N; Abdillahi M; Zhu Z; Qu W; Rosario R; Touré F; Yan SF; Schmidt AM; Ramasamy R
PLoS One; 2010 Apr; 5(4):e10092. PubMed ID: 20404919
[TBL] [Abstract][Full Text] [Related]
8. Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway.
Finsen AV; Lunde IG; Sjaastad I; Østli EK; Lyngra M; Jarstadmarken HO; Hasic A; Nygård S; Wilcox-Adelman SA; Goetinck PF; Lyberg T; Skrbic B; Florholmen G; Tønnessen T; Louch WE; Djurovic S; Carlson CR; Christensen G
PLoS One; 2011; 6(12):e28302. PubMed ID: 22164265
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
[TBL] [Abstract][Full Text] [Related]
10. Panax notoginseng saponins alleviate skeletal muscle insulin resistance by regulating the IRS1-PI3K-AKT signaling pathway and GLUT4 expression.
Guo X; Sun W; Luo G; Wu L; Xu G; Hou D; Hou Y; Guo X; Mu X; Qin L; Liu T
FEBS Open Bio; 2019 May; 9(5):1008-1019. PubMed ID: 30945455
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
[TBL] [Abstract][Full Text] [Related]
12. Excessive treadmill training enhances the insulin signaling pathway and glycogen deposition in mice hearts.
Oliveira LDC; de Morais GP; da Rocha AL; Teixeira GR; Pinto AP; de Vicente LG; Pauli JR; de Moura LP; Mekary RA; Ropelle ER; Cintra DE; da Silva ASR
J Cell Biochem; 2019 Feb; 120(2):1304-1317. PubMed ID: 30324688
[TBL] [Abstract][Full Text] [Related]
13. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J
Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568
[TBL] [Abstract][Full Text] [Related]
14. Regulation of dishevelled and beta-catenin in rat skeletal muscle: an alternative exercise-induced GSK-3beta signaling pathway.
Aschenbach WG; Ho RC; Sakamoto K; Fujii N; Li Y; Kim YB; Hirshman MF; Goodyear LJ
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E152-8. PubMed ID: 16478782
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
[TBL] [Abstract][Full Text] [Related]
16. Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
Li G; Xie J; Chen J; Li R; Wu H; Zhang X; Chen Q; Gu R; Xu B
Cardiovasc Pathol; 2017; 28():74-79. PubMed ID: 28395201
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-4 Signaling Is Required for Exercise-Induced Cardiac Hypertrophy.
Xie J; He G; Chen Q; Sun J; Dai Q; Lu J; Li G; Wu H; Li R; Chen J; Xu W; Xu B
Mol Med; 2016 Sep; 22():192-201. PubMed ID: 26835698
[TBL] [Abstract][Full Text] [Related]
18. The cardiac syndecan-4 interactome reveals a role for syndecan-4 in nuclear translocation of muscle LIM protein (MLP).
Mathiesen SB; Lunde M; Aronsen JM; Romaine A; Kaupang A; Martinsen M; de Souza GA; Nyman TA; Sjaastad I; Christensen G; Carlson CR
J Biol Chem; 2019 May; 294(22):8717-8731. PubMed ID: 30967474
[TBL] [Abstract][Full Text] [Related]
19. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.
Wende AR; Kim J; Holland WL; Wayment BE; O'Neill BT; Tuinei J; Brahma MK; Pepin ME; McCrory MA; Luptak I; Halade GV; Litwin SE; Abel ED
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1098-H1108. PubMed ID: 28822962
[TBL] [Abstract][Full Text] [Related]
20. Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72.
Ham YM; Mahoney SJ
Exp Cell Res; 2013 Jun; 319(10):1451-62. PubMed ID: 23567182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
